| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710530 | Null | 0.00227238673876898 | 0.19937885 |
| NSC 698088 | Null | 0.00306027196853062 | -0.1547582 |
| NSC 731154 | 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno [1,2-c]isoquinoline | 0.00306027196853062 | -0.0080730542 |
| NSC 732937 | 6-(3-Azidopropyl)-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline | 0.00306027196853062 | -0.06100413 |
| NSC 742295 | (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.00306027196853062 | 0.22316705 |
| NSC 685272 | D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone | 0.00347157511980527 | 0.041101221 |
| NSC 689140 | 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 9-methyl-5-phenyl- | 0.00347157511980527 | 0.33394701 |
| NSC 623794 | 1,4-Benzodioxin-2-carboxamide, 6-(4-oxo-4-H-1- benzopyran-2-yl)-N-(3-pyridinylmethyl)- | 0.00347157511980532 | 0.11406764 |
| NSC 357704 | Cyanomorpholinodoxorubicin | 0.00404192617431249 | 0.21153571 |
| NSC 661421 | Null | 0.00404192617431249 | -0.26050553 |